Analysis Indoco Remedies Limited (INDOCO)
6/3/2024
Analysis of Indoco Remedies Limited (INDOCO)
Based on the provided data for Indoco Remedies Limited, we can observe the following:1. **Price Movement**: The stock price has been fluctuating over the past few days, with the price closing at 337.79999 on the latest available date.
2. **Relative Strength Index (RSI)**: The RSI indicator is around 60.31888, indicating that the stock is neither overbought nor oversold at the moment.
3. **Moving Average Convergence Divergence (MACD)**: The MACD indicator is -4.46883, which is below the signal line (-5.60036). The MACD histogram is positive (1.13153), suggesting a potential bullish momentum.
4. **Moving Averages (MA)**: The Simple Moving Average (SMA) is at 321.52400, Exponential Moving Average (EMA) at 322.22405, and Weighted Moving Average (WMA) at 319.06602. These moving averages can be used to identify trends in the stock price.
5. **Overall Analysis**: The stock seems to be in a consolidation phase with mixed signals from the technical indicators. Traders and investors may need to monitor the price action closely for a clearer trend direction.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released After Hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The fiscal year ends on September 30, 2023, and the most recent quarter reported is March 31, 2024.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has 15.39 million shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The market capitalization is $2.92 trillion.
Stock price summary indicates a beta of 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The stock's 52-week low is $164.08, high is $199.62, and the change over the past year is 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date set for May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, from $66.3 billion in 2020 to $114.3 billion in 2023.
4. Net income has been growing consistently, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA increasing from $81 billion in 2020 to $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been able to effectively manage its operating expenses, as seen in the growth of operating income outpacing the increase in sales revenue.
9. Non-operating interest expenses have been relatively stable over the years.
10. The number of basic and diluted shares outstanding has remained constant, indicating no significant dilution of shares.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been taking on more debt over the years, as indicated by the increasing trend in total liabilities.
8. The fluctuations in shareholders' equity indicate changes in the company's profitability and retained earnings over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant cash outflows, mainly due to common stock repurchases and debt payments.
6. Investing activities have also seen significant cash flows, with the sale and purchase of investments impacting the overall cash position.
7. The company has been consistent in paying dividends and issuing debt to manage its financing activities.
8. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that have influenced its cash position over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. The EPS estimate is also higher than the $1.35 reported in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, analysts project an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a slight increase from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. Again, 25 analysts have contributed to these estimates.
For the current fiscal year ending on September 30, 2024, the average estimate for total sales is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the full year increases to 38.
Finally, for the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term, with a slightly more optimistic outlook for the next fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still expected to be robust.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.
MACD of INDOCO
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
